Regulation of transforming growth factor-β1 expression by the hepatitis B virus (HBV) X transactivator: Role in HBV pathogenesis

Journal of Clinical Investigation

Volumn 97, Issue 2, 1996, Pages 388-395

  Yoo, Young Do ^a   Ueda, Hiroyuki ^b   Park, Keunchil ^a,d   Flanders, Kathy C ^a   Lee, Young Ik ^c   Jay, Gilbert ^b   Kim, Seong Jin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HOLLAND LABORATORY   (United States)

^c Korea Institute of Science and Technology   (South Korea)

^d SaraSung Medical Center   (South Korea)

Author keywords

Hepatitis B virus; Hepatocellular carcinoma; Immunohistochemistry; TGF 1; Transcription

Indexed keywords

HEPATITIS B ANTIGEN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEP 2 CELL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TRANSACTIVATION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION, VIRAL; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; IMMEDIATE-EARLY PROTEINS; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; STRUCTURE-ACTIVITY RELATIONSHIP; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030032374     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118427     Document Type: Article

References (67)

1. Beasley, R. P., C. C. Lin, L. Y Hwang, and C. S. Chien. 1981 Hepatocellular carcinoma and hepatitis B virus. Lancet, ii.1129-1133
2. Tiollais. P , C. Pourcel. and A. Dejean. 1985. The hepatitis B virus Nature (Lond.). 317:489-495.
3. Kay, A., E. Mandart, C. Trepo, and F. Galibert. 1985. The HBV HBx gene expressed in E. coli is recognised by sera from hepatitis patients EMBO (Ear. MoL Biol Organ.) J 4:1287-1292.
4. Moriarty, A. M., H. Alexander, R A. Lerner, and G. B. Thornton. 1985. Antibodies to peptides detect new hepatitis B antigen: serologicai correlation with hepatocellular carcinoma. Science (Wash. DC), 227:429-432.
5. Siddiqui, A , S Jameel, and J. Mapoles. 1987. Expression of the hepatitis B virus X gene in mammalian cells. Proc. Natl. Acad. Sci. USA. 84:2523-2517.
6. Wang, W., W. T. London, L. Lega, and M. A. Feitelson. 1991. HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology. 14:29-37.
7. Chen, H.-S., S. Kaneko, R. Girones, R. W. Anderson, W. B Hornbuckle, B. C. Tennant, P. J. Cote, J. L. Gerin, R. H. Purcell, and R. H. Miller. 1993. The woodchuck hepatitis virus x gene is important for establishment of virus infection in woodchucks. J Virol. 67-1218-1226.
8. Levrero, M., C. Balsano, G. Natoli, M. L. Avantaggiati, and E. Elfassi 1990. Hepatitis B virus X protein transactivates the long terminal repeats of human immunodeficiency virus type 1 and 2. J. Virol. 64:3082-3086.
9. Seto, E., D.-X. Zhou, B. M. Peterlin, and T. S. B Yen. 1989 Trans-activation by the hepatitis B virus X protein shows cell-type specificity. Virology 173:764-766.
10. Siddiqui, A., R. Gaynor, A. Srinivasan, J. Mapoles, and R. W. Farr. 1989. Trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein. Virology. 169:479-494.
11. Twu. J. S., and R. H. Schloemer. 1987. Transcriptional trans-activating function of hepatitis B virus. J. Virol. 61:3448-3453.
12. Twu, J. S., and W. S. Robinson. 1989. Hepatitis B virus X gene can transactivate heterologous viral sequence. Proc. Natl Acad. Sci. USA. 86:2046-2050.
13. Twu, J. S., M Y. Lai, D, S. Chen, and W. S. Robinson. 1993. Activation of the proto-oncogene c-Jun by the X protein of hepatitis B virus. Virology. 192-346-350.
14. Seto, E., P J. Mitchell, and T. S. B. Yen. 1990. Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature (Lond.). 344:72-74.
15. Maguire, H. F., J. P Hoeffler, and A. Siddiqui. 1991. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein inter-actions. Science (Wash. DC). 252:842-844.
16. Kekulé, A. S., U. Lauer. L. Weiss, B Luber, and P. H. Hofschneider 1993. Hepatitis B virus transactivator HBx uses a tumor promoter signalling pathway. Nature (Lond). 361:742-746.
17. Kim, C-M., K. Koike, I. Saito, T. Miyamura, and G. Jay. 1991. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (Lond). 351:317-320.
18. Ueda, H., S. J. Ullich, J. D. Gangemi, C. A. Kappel, L Ngo, M. A. Feitelson, and G. Jay. 1995. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat. Genet. 9:41-47.
19. Andus, T. J. Bauer, and W Gerok. 1991 Effects of cytokines on the liver. Hepatology. 13:364-375.
20. Braun, L , J E. Mead, M. Panzica, R. Mikumo, G. I. Bell, and N. Fausto. 1988. Transforming growth factor β mRNA increases during liver regeneration a possible paracrine mechanism of growth regulation. Proc. Natl. Acad. Sci USA 85:1539-1543.
21. Fausto. N., and J. E. Mead. 1989. Regulation of liver growth: protooncogenes and transforming growth factors. Lab. Invest 60:4-13.
22. Nakamura, T., Y. Tomita, R. Hirai, K. Yamaoka, K. Kaji, and A. Ichihara. 1985. Inhibitory effect of transforming growth factor-β on DNA synthesis of adult rat hepatocytes in primary culture. Biochem. Biophys. Res. Commun. 133:1042-1050.
23. Czaja, M. J., F. R. Weiner, K. C. Flanders, M. A. Giambronc, R. Wind. L. Biempica, and M. A. Zern. 1989. In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J. Cell Biol 108-2477-2482.
24. Nakatsukasa, H., P Nagy, R. P. Evarts, L C. Hsia, E. Marsden. and S. S. Thorgeirsson. 1990. Cellular distribution of transforming growth factor-β1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin. Invest. 85:1833-1843.
25. Castilla, A., J. Prieto, and N. Fausto. 1991. Transforming growth factor β1 and α in chronic liver disease: effects of interferon-α therapy. N Eng. J. Med 324-933-940.
26. Ito, N., S. Kawata, S. Tamura, K. Takaishi, Y. Shirai, S. Kiso, I. Yabuuchi, Y. Matsudo, M Nishioka, and S Tarui. 1991. Elevated levels of transforming growth factor-β messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer Res. 51:4080-4083.
27. Heine, U. I., K. C. Flanders. A. B. Roberts, E. F. Munoz, and M. B. Sporn. 1987 Role of transforming growth factor β in the development of the mouse embryo J. Cell Biol. 105:2861-2876.
28. Flanders, K. C, N L. Thompson, D. S. Cissel. E. Van Obberghen-Schilling, C. C. Baker, M. E. Kass, R Ellingsworth, A. B. Roberts, and M B. Sporn. 1989. Transforming growth factor-β1. histochemical localization with antibodies to different epitopes. J. Cell Biol 108:653-660.
29. Kim. S.-J., K. Park, B B. Rudkin, B. R. Dey, M. B. Sporn, and A. B. Roberts. 1994. Nerve growth factor induces transcription of transforming growth factor-β1 through a specific promoter element in PC12 cells. J Biol Chem. 269:3739-3744.
30. Cao, X , R. A. Koski, A Gashler, M. McKiernan, C. F. Morris, R. Gaffney, R. V. Hay, and V. P. Sukhatme. 1990. Identification and characterization of the Egr-1 gene product, a DNA-binding protein induced by differentiation and growth signals Mol Cell. Biol. 10.1931-1939.
31. Liu, F., and M R. Green. 1990. A specific member of the ATF transcription factor family can mediate transcription activation by the adenovinis EIa protein. Cell. 61:1217-1224.
32. 2+-regulated transcription factor phosphorylated by calmodulin-deperident kinases. Science (Wash. DC) 252:1427-1430
33. Lillie, J W., and M. R. Green. 1989. Transcription activation by the adenoviius E1A protein. Nature (Lond.). 338:39-44.
34. Sadowski. I., J. Ma, S. Triszenberg. and M. Ptashne. 1988. GAL4-VP16 is an unusually potent transcriptional activator. Nature (Lond.) 335-563-564.
35. Frankel, S., R. Sohn, and L Leinwand. 1991. The use of sarkosyl in generating soluble protein after bacterial expression. Proc. Natl. Acad Sci, USA. 83:1192-1196.
36. Kim, S.-J., A. Glick, M. B. Sporn, and A. B. Roberts. 1989. Characterization of the promoter region of the human transforming growth factor-β1 gene. J. Biol Chem. 264:402-408.
37. Gilardi, P., and M. Perricaudet. 1984. The E4 transcriptional unit of Ad2: far upstream sequences are required for its transactivation by E1A. Nucleic Acids Res. 12.7877-7888.
38. Kwee, L., R. Lucito, B. Aufiero, and R. J. Schneider. 1992. Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters. J. Virol. 66: 4382-4389.
39. Arii, M., S. Takada, and K. Koike. 1992. Identification of three essential regions of hepatitis B virus X protein for transactivation function. Oncogene. 7-397-403.
40. Wang, X. W., K. Forrester, H. Yeh. M. A. Feitelson, J.-R. Gu, and C. C. Harris. 1994. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. Natl. Acad. Sci. USA. 91:2230-2234.
41. Colgrove, R., S Gwynn, and D. Ganem. 1989. Transcriptional activation of homologous and heterologous genes by the hepatitis B virus gene product in cells permissive for viral replication. J Virol. 63:4019-4026.
42. Lim, R. W., B. C. Varnum, and H R Herschman. 1987. Cloning of tetradecanoyl phorbol ester-induced "primary response" sequences and their expression in density-arrested Swiss 3T3 cells and a TPA nonproliferative variant. Oncogene. 1:263-270.
43. Lau, L. F., and D. Nathans. 1987. Expression of a set of growth-related immediate early genes in BALB/c3T3 cells: coordinate regulation with c-fos and c-myc. Proc. Natl. Acad. Sci. USA. 84:1182-1186.
44. Christy, B. A., L. F. Lau, and D. Nathans. 1988. A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with zinc finger sequences. Proc. Natl. Acad Sci. USA. 85:7857-7861.
45. Christy, B. A., and D. Nathans. 1989. DNA binding site of the growth factor-inducible protein Zif268 Proc. Natl Acd. Sci. USA. 86:8737-8741.
46. Lemaire, P., O. Relevant, R. Bravo, and P. Charnay. 1988. Two mouse genes encoding potential transcription factors with identical DNA-binding domains are activated by growth factors in cultured cells. Proc. Natl. Acad. Sci. USA 85:4691-4695.
47. Milbrandt, J. 1987. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science (Wash. DC). 238:797-799.
48. Sukhatme, V. P. 1990. Early transcriptional events in cell growth: the Egr family. J Am. Soc Nephrol 1:859-866
49. Madden, S. L., D. M. Cook, J. F. Morris, A. Gashler, V. P. Sukhatme, and F. J. Rauscher III. 1991. Transcriptional repression mediated by the WT1 Wilm's tumor gene product. Science (Wash. DC). 253:1550-1553.
50. Rauscher III, F. J., J. F. Morris, T. J. Tournay, D. M. Cook, and T. Curran. 1990. Binding of the Wilm's tumor locus zinc finger protein to the egr-1 consensus sequence. Science (Wash. DC). 250:1258-1262.
51. Drummond, I. A., S. L. Madden, P. Rohwer-Nutter, G. I. Bell. V. P. Sukhatme, and F. J. Rauscher III. 1992. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science (Wash. DC). 257: 674-677.
52. Takada. S., and K. Koike. 1990. Trans-activation function of a 3' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proc. Natl. Acad. Sci. USA. 87:5628-5632.
53. Unger, T., and Y Shaul. 1990. The X-protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive clement, EMBO (Eur. Mol. Biol. Organ.) J. 9:1889-1895.
54. Ritter, S E., T. M. Whitten, A. T. Quets, and R. H. Schloemer. 1991. An internal domain of the hepatitis B virus antigen is necessary for transactivating activity. Virology. 182:841-845.
55. Kim, S.-J., S. Wagner, F. Liu, M. A. O'Reilly, P D. Robbins, and M. R. Green. 1992. Retinoblastoma gene product activates expression of the human TGF-p2 gene through transcription factor ATF-2. Nature (Lond.). 358:331-334.
56. Yamamoto, K. K., G. A. Gonzalez, W. H. Briggs III, and M. R. Montminy 1988. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature (Lond.). 334:494-498.
57. Gonzalez, G. A., and M. R. Montiminy. 1989. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell. 59:675-680.
58. Natori, G., M. L. Avantaggiati, P. Chirillo, A. Costanzo, M. Artini, C. Balsano, and M. Levrero 1994. Induction of the DNA-binding activity of c-Jun/ c-Fos heterodimers by the hepatitis B virus transactivator pX. Mol. Cell. Biol. 14:989-998.
59. Boyle, W. J., T. Smeal. L. H. K. Defize, P. Angel, I. R. Woodgett, M. Karin, and T. Hunter. 1991. Activation of protein kinase C decreases phosphorylation of c-Jun at serines that negatively regulate its DNA-binding activity. Cell. 64:573-584
60. Tratner, J., R Ofir, and I M Verma. 1992. Alteration of a cyclic AMP-dependent protein kinase phosphorylation site in the c-Fos protein augments its transforming potential. Mol. Cell Biol 12:998-1006.
61. 4-induced hepatic fibrosis. Hepatology. 8.259-266.
62. Robert, A. B., and M. B. Sporn. 1990. The transforming growth factor-βs. Peptide growth factors and their receptors, part I. M. B. Sporn and A. B. Roberts, editors. Springer-Verlag, Berlin. 419-472.
63. Sporn, M. B., and A. B. Roberts. 1985. Autocrine growth factors and cancer. Nature (Lond.). 313.747-749.
64. Derynck, R., D. V Goeddel. A. Ullrich, J V. Gutterman. R D Williams, T. S. Bringman, and W. H. Berger. 1987. Synthesis of messenger RNAs for transforming growth factors αand β and the epidermal growth factor receptor by human tumors Cancer Res. 47:707-712.
65. Kim. S.-J., J. H. Kehrl, J. Burton, C. L. Tendler, K.-T. Jeang, D. Danielpour, C. Thevenin, K. Y. Kim, M. B. Sporn, and A. B. Roberts. 1990. Transactivation of the transforming growth factor β1 (TGF-β1) gene by human T lymphotrophic virus type 1 tax: a potential mechanism for increased production of TGF-β1 in adult T cell leukemia. J. Exp. Med, 172:121-129
66. Unsal, H., Y. Cengiz, C. Marcais, M Kew, M. Volkmann, H. Zentgraf, K. J. Isselbacher, and M. Ozturk. 1994. Genetic heterogeneity of hepatocellular carcinoma. Proc. Natl. Acad Sci USA. 91:822-826.
67. Wang, W., W. T London, and M. A. Feitelson. 1991. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res 51:4971-4977.